Michel Eichelbaum
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 0.05%
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 161
- Pharmacogenetics and Drug Metabolism 147
- Antibiotics Pharmacokinetics and Efficacy 25
- Oncology 120
- Drug Transport and Resistance Mechanisms 100
- Co-authors
- Ulrich M. Zanger (53 shared papers)Matthias Schwab (71 shared papers)Oliver Burk (23 shared papers)Martin F. Fromm (37 shared papers)Ulrich Brinkmann (9 shared papers)Oliver von Richter (10 shared papers)Elke Schaeffeler (24 shared papers)Heyo K. Kroemer (21 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (30 papers)British Journal of Clinical Pharmacology (27 papers)European Journal of Clinical Pharmacology (26 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (11 papers)Pharmacogenetics and Genomics (9 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Michel Eichelbaum
339 papers receiving 25.4k citations
Michel Eichelbaum's Hit Papers
Peers
Comparison fields: 5 of 167
- Pharmacology 11.7k
- Oncology 10.6k
- Pediatrics, Perinatology and Child Health 5.9k
- Transplantation 622
- Pharmacology 2.3k
Countries citing papers authored by Michel Eichelbaum
This map shows the geographic impact of Michel Eichelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Eichelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Eichelbaum more than expected).
Fields of papers citing papers by Michel Eichelbaum
This network shows the impact of papers produced by Michel Eichelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Eichelbaum. The network helps show where Michel Eichelbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Michel Eichelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 352 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Hit paper breakdown → | 2000 | 2028 |
| 2 | The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin Hit paper breakdown → | 1999 | 780 |
| 3 | Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin Hit paper breakdown → | 2001 | 734 |
| 4 | Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry Hit paper breakdown → | 2004 | 652 |
| 5 | Pharmacogenomics and Individualized Drug Therapy Hit paper breakdown → | 2005 | 543 |
| 6 | Defective N-oxidation of sparteine in man: A new pharmacogenetic defect Hit paper breakdown → | 1979 | 527 |
| 7 | 2003 | 435 | |
| 8 | 2007 | 355 | |
| 9 | 2004 | 353 | |
| 10 | 2004 | 353 | |
| 11 | 1996 | 347 | |
| 12 | 1990 | 317 | |
| 13 | 2005 | 306 | |
| 14 | 2008 | 305 | |
| 15 | 1995 | 288 | |
| 16 | 2002 | 269 | |
| 17 | 2003 | 257 | |
| 18 | 2003 | 252 | |
| 19 | Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. | 1991 | 238 |
| 20 | 1998 | 233 |
About Michel Eichelbaum
Michel Eichelbaum is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology, having authored 352 papers that have together received 26.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (147 papers), Drug Transport and Resistance Mechanisms (100 papers), Pharmacological Effects and Toxicity Studies (54 papers), Analytical Chemistry and Chromatography (35 papers), Metabolism and Genetic Disorders (26 papers), Antibiotics Pharmacokinetics and Efficacy (25 papers), Botanical Research and Chemistry (22 papers) and Epilepsy research and treatment (21 papers). The work is most often cited by research in Pharmacology (11.7k citations), Oncology (10.6k citations), Pediatrics, Perinatology and Child Health (5.9k citations), Transplantation (622 citations) and Pharmacology (2.3k citations). Michel Eichelbaum has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ulrich M. Zanger, Matthias Schwab, Oliver Burk, Martin F. Fromm, Ulrich Brinkmann, Oliver von Richter, Elke Schaeffeler, Heyo K. Kroemer, Sebastian Raimundo and Anke Geick. Their work appears in journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.